Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire

[1]  D. Murrell,et al.  The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use? , 2017, Acta dermato-venereologica.

[2]  D. Murrell,et al.  Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA , 2015, Quality of Life Research.

[3]  H. Miot,et al.  Quality of life index in autoimmune bullous dermatosis patients* , 2015, Anais brasileiros de dermatologia.

[4]  D. Murrell,et al.  Outcome measures for autoimmune blistering diseases , 2015, The Journal of dermatology.

[5]  T. Nijsten,et al.  Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire. , 2013, JAMA dermatology.

[6]  T. Nijsten,et al.  Measurement of health‐related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  Vineet Kumar,et al.  Psychiatric morbidity in pemphigus and psoriasis: a comparative study from India. , 2013, Asian journal of psychiatry.

[8]  Lishou Xiong,et al.  Life quality of Chinese patients with chronic urticaria as assessed by the dermatology life quality index , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  Yang Zhang,et al.  The 36-Item Short Form Health Survey: Reliability and Validity in Chinese Medical Students , 2012, International journal of medical sciences.

[10]  C. Di Pietro,et al.  Quality of life in patients with pemphigus receiving adjuvant therapy , 2012, Clinical and experimental dermatology.

[11]  C. Chams‐Davatchi,et al.  Quality of life and psychological status of patients with pemphigus vulgaris using Dermatology Life Quality Index and General Health Questionnaires , 2012, The Journal of dermatology.

[12]  J. R. McMillan,et al.  Quality of life in patients with bullous dermatoses. , 2012, Clinics in dermatology.

[13]  M. Sticherling,et al.  Autoimmune blistering diseases of the skin. , 2012, Autoimmunity reviews.

[14]  M. Meurer.  Immunosuppressive therapy for autoimmune bullous diseases. , 2012, Clinics in dermatology.

[15]  Z. Ghodsi,et al.  MENTAL HEALTH IN PATIENTS WITH PEMPHIGUS: AN ISSUE TO WORTH CONSIDERATION , 2011, Indian journal of dermatology.

[16]  C. Di Pietro,et al.  Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools. , 2009, Journal of the American Academy of Dermatology.

[17]  H. Shimizu,et al.  Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. , 2008, Journal of the American Academy of Dermatology.

[18]  D. Abeni,et al.  The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36‐item short form health survey questionnaire , 2008, The British journal of dermatology.

[19]  Jason W. Osborne,et al.  Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. , 2005 .

[20]  M. Chren,et al.  Scalpdex: a quality-of-life instrument for scalp dermatitis. , 2002, Archives of dermatology.